Regulation of the Inflammasome by Ceramide in Cystic Fibrosis Lungs
Author(s) -
Heike Grassmé,
Alexander Carpinteiro,
Michael J. Edwards,
Erich Gulbins,
Katrin Anne Becker
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000362983
Subject(s) - inflammasome , ceramide , acid sphingomyelinase , inflammation , pyroptosis , occludin , biology , microbiology and biotechnology , cystic fibrosis transmembrane conductance regulator , caspase 1 , tight junction , cystic fibrosis , immunology , chemistry , cancer research , apoptosis , biochemistry , genetics
Cystic fibrosis (CF), the most common autosomal recessive disorder in Western countries, is characterized by chronic pulmonary inflammation, reduced mucociliary clearance, and increased susceptibility to infection. Our studies using Cftr-deficient mice and human CF specimens showed that ceramide accumulates in CF lungs and mediates increased cell death, susceptibility to infections, and inflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom